Corporate News | 11/05/2015

RHÖN-KLINIKUM AG Prepares for the Future - Appointment of Prof. Dr. Bernd Griewing to the Board of Management - Modified Departmental Responsibilities an Standardised Contractual Terms

DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Change of Personnel/Change of Personnel2015-11-05 / 16:30

Corporate News

RHÖN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt / Saale

RHÖN-KLINIKUM AG Prepares for the Future

Appointment of Prof. Dr. Bernd Griewing to the Board of Management

Modified Departmental Responsibilities and Standardised Contractual Terms

Bad Neustadt / Saale, 5th November 2015

RHÖN-KLINIKUM AG prepares for future business opportunities with a new organisational structure in its Board of Management. Today the company's Supervisory Board passed a resolution appointing Prof. Dr. Bernd Griewing, spokesperson for the Medical Board and Medical Director of the Neurological Clinic in Bad Neustadt, to the Board of Management from 1st January 2016. As well as continuing to develop the Medical Board Griewing in his new position as Chief Medical Officer (CMO) will be responsible for the areas of patient safety, quality and hygiene, medical process management as well as innovation and network medicine.

The Supervisory Board also passed a resolution to modify the departmental responsibilities in the Board of Management at the same time. In future the CEO Dr. Martin Siebert will be responsible for the further development of the university hospitals in Giessen and Marburg. The areas of personnel/salaries and communication as well as the specialist area of law and the departments of compliance, internal revision and group headquarters and the hospitals on the RHÖN-KLINIKUM campus in Bad Neustadt will also be under his responsibility.

As CFO Jens-Peter Neumann will be responsible for the areas of accounting, taxes and controlling, IT, Building and Technology as well as Investor Relations and Finance.

In future Martin Menger, COO, will be responsible for the areas of materials management, services and logistics as well as post-merger integration. The Central Clinic in Bad Berka and the hospital in Frankfurt/Oder will also remain under his responsibility.

Furthermore the terms of the service agreements of the Board of Management will be standardised. All the members will now receive a five-year agreement, each starting on 1st January 2016.

"By modifying the departmental responsibilities within the Board of Management we have now created a structure which perfectly reflects our corporate strategy geared towards maximum medical care and considerably strengthens our entrepreneurial prospects for the future. Together with my colleagues on the Board of Management I am very much looking forward to further developing RHÖN-KLINIKUM AG in the next few years as an innovative, growth-orientated hospital operator," CEO Dr. Martin Siebert said.


RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. With ten hospitals in five locations and a total of roughly 5,300 beds we offer affordable cutting-edge medical care with a direct link to universities and research institutes. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. A total of over 15,000 employees work for RHÖN-KLINIKUM AG.

Further information is available at:

Your Contact Persons:


Achim StruchholzHead of Corporate CommunicationSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1327Facsimile: + 49 - 9771 65-1820E-Mail: kommunikation(at)

Dr. Kai G. KlingerHead of Investor RelationsSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1318Facsimile: + 49 - 9771 99-1736E-Mail: kai.klinger(at)

2015-11-05 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at and
Language: English
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart
End of News DGAP News Service

409587  2015-11-05